Unclaimed brand
BetaLife is a stem cell therapy company in Singapore, that is focused on regenerative medicine for diabetes. Learn more about us today.
Liking this brand profile? Share this page
Hex Code
Color name
RGB
HSL
CMYK
#007BB6
Deep Cerulean
0, 123, 182
199, 100, 36
100, 32, 0, 29
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
#006A74
Pine Green
0, 106, 116
185, 100, 23
100, 9, 0, 55
BetaLife is a Singapore-based stem cell therapy company focused on regenerative medicine for diabetes. Founded by scientists with more than a decade of experience and a track record in diabetes and stem cell research, the company is supported by a network of clinicians and innovators in diabetes and organ transplantation. Its work centers on next-generation regenerative approaches using human induced pluripotent stem cells (hiPSCs).
BetaLife is developing pancreatic islet cells from high-quality, clinical-grade hiPSCs for cell replacement therapy. The aim is to produce islet cells with superior functionality and, through its hiPSC platform, ultimately create off-the-shelf cell products intended to improve life for people with diabetes. The company says its platform may also have potential across other clinical indications in the future.
BetaLife’s website provides information about its science and technology, cell replacement therapy, stem cell banking, quality control, and resources for institutions. It also shares publications and educational materials, and introduces its team and facilities. The company operates offices in Singapore and China.
Company type
Privately Held
Year founded
2020
Company size
2-10 employees
The BetaLife name, logos and brand assets are trademarks of BetaLife and its affiliates. Brandfetch isn't affiliated with or endorsed by BetaLife. Their use is subject to BetaLife's brand guidelines.
